AVArx review

AVArx names AVArx LLC and Arora Health & Aesthetics and describes state-specific visit requirements. No numeric sermorelin or NAD⁺ price was found on the reviewed public pages. Its homepage qualifies state availability and advertises free expedited delivery, while the shipping policy claims all 50 states and allows checkout shipping charges. Confirm the terms for your actual treatment.

AVArx is a telehealth technology platform operated by AVArx LLC of Glendale, California. It is explicit that it is not a pharmacy, a medical practice or a healthcare provider: care is delivered by independent licensed providers of Arora Health & Aesthetics, LLC, with a published medical-compliance contact. Its wellness line covers sermorelin, sermorelin troches, NAD⁺ injection, NAD⁺ nasal spray and glutathione, alongside semaglutide and tirzepatide injections.

The homepage lists states requiring live audio or video visits and identifies Arora Health & Aesthetics as its affiliated provider group. These are platform disclosures, not independent credential verification or patient-specific clinician assignment. Its FAQ makes eligibility dependent on provider and pharmacy authorization, despite an all-50-state shipping claim. The policy lists 1–3 business days of processing plus 3–7 delivery, differing from homepage 3–5-day and free-expedited promises. Ask which applies to your order.

No numeric sermorelin or NAD⁺ price was found on reviewed public treatment pages. The terms place recurring amount and frequency at enrollment; ask for medication supply, full debit, consultation and shipping fees, and renewal terms. Consultation fees are generally nonrefundable after provider review. Prescriptions cannot be canceled or refunded once dispensed and shipped; request cancellation before that point. Report damaged, lost or incorrect orders within seven days. Homepage dashboard cancellation does not undo those cutoffs.

Prescription required only if a licensed provider finds it appropriate. The reviewed AVArx treatment pages did not establish the compounded-versus-brand status of its sermorelin, NAD⁺, glutathione or GLP-1 products. Peptide products of this kind are usually compounded, and compounded medications are not FDA-approved and not therapeutically equivalent to branded drugs, so establishing which you are being sold is the first question to ask at intake. No dispensing pharmacy is named either, described only as an independent, licensed U.S. pharmacy partner. On the evidence, the molecules themselves are unchanged by any of that. Sermorelin acts on the growth-hormone axis, a real mechanism with thin long-term outcome data, and the troche format carries an extra caveat, since peptides are poorly absorbed by non-injected routes and we have seen no controlled data showing a troche matches an injection. Injected and intranasal NAD⁺ have no controlled human outcome trials; oral NR and NMN are the studied forms, demonstrating a raised blood NAD⁺ level rather than a clinical benefit. Injectable glutathione has essentially no controlled human outcome evidence. Individual results vary.